These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 911870)

  • 1. Mechanism for elevation of hepatic cholesterol synthesis and serum cholesterol levels in triton WR-1339-induced hyperlipidemia.
    Kuroda M; Tanzawa K; Tsujita Y; Endo A
    Biochim Biophys Acta; 1977 Oct; 489(1):119-25. PubMed ID: 911870
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid increase in hepatic HMG CoA reductase activity and in vivo cholesterol synthesis after Triton WR 1339 injection.
    Goldfarb S
    J Lipid Res; 1978 May; 19(4):489-94. PubMed ID: 659987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of desoxymevalonic acid derivatives on development of triton hyperlipemia in rats].
    Klimov AN; Klimova TA; Poliakova ED; Dizhe EB; Petrova LA
    Vopr Med Khim; 1974; 20(1):65-9. PubMed ID: 4454273
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activities of 3-hydroxyl-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and the rate of mevalonic acid, squalene, sterol and fatty acid biosynthesis from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: effects of Triton WR 1339, starvation and cholesterol diet].
    Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
    Biokhimiia; 1981 Feb; 46(2):296-305. PubMed ID: 6113854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals.
    Endo A; Tsujita Y; Kuroda M; Tanzawa K
    Biochim Biophys Acta; 1979 Nov; 575(2):266-76. PubMed ID: 508786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Hydroxy-3-methylglutaric acid and triton-induced hyperlipidemia in rats.
    Yousufzai SY; Siddiqi M
    Experientia; 1976 Sep; 32(9):1178-9. PubMed ID: 183980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of correlation between the rate of cholesterol biosynthesis and the activity of 3-hydroxy-3-methylgutaryl coenzyme A reductase in rats and in fibroblasts treated with ML-236B.
    Bensch WR; Ingebritsen TS; Diller ER
    Biochem Biophys Res Commun; 1978 May; 82(1):247-54. PubMed ID: 666838
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal by triton WR-1339 of ethynyloestradiol-induced hepatic cholesterol esterification.
    Davis RA; Showalter R; Kern F
    Biochem J; 1978 Jul; 174(1):45-51. PubMed ID: 697762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetate 14C incorporation in hepatic and plasmatic cholesterol during triton-induced hyperlipemia.
    Breillot J; Fourçans B; Melin B; Piot MC; Alcindor LG; Polonovski J
    Steroids Lipids Res; 1974; 5(2):96-100. PubMed ID: 4428494
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship between changes in the concentration of serum lipoproteins and tissue lipogenesis: effect of Triton WR-1339 [proceedings].
    Fears R; Umpleby AM
    Biochem Soc Trans; 1978; 6(3):600-2. PubMed ID: 669026
    [No Abstract]   [Full Text] [Related]  

  • 11. The in vitro effects of Triton WR-1339 on lipid synthesis by bone cells.
    McPherson JC; Schuster GS; Dirksen TR
    Proc Soc Exp Biol Med; 1975 May; 149(1):172-7. PubMed ID: 1144422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Endo A; Tsujita Y; Kuroda M; Tanzawa K
    Eur J Biochem; 1977 Jul; 77(1):31-6. PubMed ID: 908337
    [No Abstract]   [Full Text] [Related]  

  • 13. Antilipidemic activity of 4-oxo-functionalized ethyl 6-chlorochroman-2-carboxylate analogs and a related tricyclic lactone in three rat models.
    Cavestri RC; Minatelli JA; Baldwin JR; Loh W; Feller DR; Newman HA; Sober CL; Witiak DT
    Lipids; 1981 Jan; 16(1):30-6. PubMed ID: 7219078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hydrophobic surfactant and cholestyramine on lipid and sterol balance in the rat.
    Bochenek WJ; Rodgers JB
    Exp Mol Pathol; 1980 Oct; 33(2):223-30. PubMed ID: 7418867
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition by plant growth retardants of cholesterol biosynthesis in slices of rat liver and hepatoma.
    Paleg L; Sabine JR
    Aust J Biol Sci; 1971 Dec; 24(6):1125-30. PubMed ID: 4359980
    [No Abstract]   [Full Text] [Related]  

  • 16. Fundamental studies on physiological and pharmacological actions of L-ascorbate 2-sulfate. I. On the hypolipidemic effects.
    Hayashi E; Yamada J; Kunitomo M; Terada M; Tomita T; Kinoshita
    J Nutr Sci Vitaminol (Tokyo); 1976; 22(3):201-8. PubMed ID: 966076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vincristine of triton WR-1339 induced hyperlipidemia in mice.
    Kremmer T; Holczinger L
    Biochem Pharmacol; 1974 Dec; 23(23):3317-21. PubMed ID: 4441418
    [No Abstract]   [Full Text] [Related]  

  • 18. The failure of nicotine to affect plasma free fatty acids and triglyceride secretion in anaesthetized rabbits given Triton WR-1339.
    Topping DL; Turner DM
    Biochem Med; 1976 Aug; 16(1):16-20. PubMed ID: 1008866
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological investigation of bezafibrate, a hypolipidemic agent (2). Mechanism of the hypolipidemic action of bezafibrate in rats].
    Kusama H; Nishiyama M; Matsubara Y; Ikeda S
    Nihon Yakurigaku Zasshi; 1988 Sep; 92(3):181-91. PubMed ID: 2907502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of Triton WR 1339 on the secretion of bile lipids in the rat].
    Melin B; Tapie M; Piot MC; Rey C; Alcindor LG; Infante R; Polonovski J
    Biomedicine; 1976 Jul; 25(6):228-31. PubMed ID: 971361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.